Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT04911660
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2021-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-06
First Submit QC Date:
None
Study First Post Date:
2021-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-11
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL